The University of Virginia Cancer Center seeks participants of any age and gender to participate in a study that will examine the safety of transplantation with unlicensed cord blood. Cord blood is blood that is taken from the umbilical cord and placenta of healthy newborn babies after childbirth. The cord blood units are provided by the National Cord Blood Program and meet the criteria for transplantation as approved by the Foundation for the Accreditation of Cellular Therapy.
Participants will be asked to remain in the study for 1 year after transplantation.
Contact Email: uvacancertrials@uvahealth.org
N/A